Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by mercedesmanon May 17, 2021 4:00pm
183 Views
Post# 33215853

RE:Dr. Kellum was great during the presentation today.

RE:Dr. Kellum was great during the presentation today.
hmmmmmmmm wrote: The promising and painful moment was at min 7:56  when Dr. Kellum said- we would be done with the TIGRIS trial by now if it were not for the disrupton caused by COVID...

Seto was also very strong. 


Even more painful is the notion that both products (PMX and CRRTs) could have been useful in the war on Covid (due to increased incidence of Sepsis and AKI).

Remains to be seen if Covid will be defeated in NA post 2021.

But's its clear Sepsis and AKI will, in the future, be at least as prevelent as it was pre-Covid.  Stats will likely show that acute and chronic kidney injury is on the rise as a result of the lasting damage done by Covid in 2020 - 2021. 

<< Previous
Bullboard Posts
Next >>